HARROW, INC.
Develops branded ophthalmic therapies and custom compounded solutions for North American eyecare.
HROW | NDAQ
Overview
Corporate Details
- ISIN(s):
- US4158581094 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 1A BURTON HILLS BLVD, 0 NASHVILLE
- Website:
- https://www.harrow.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Harrow, Inc. is an ophthalmic-focused pharmaceutical company engaged in the discovery, development, and commercialization of eyecare solutions. Formerly known as Imprimis Pharmaceuticals, the company serves eyecare professionals and their patients across North America. Its comprehensive portfolio includes a growing number of branded therapies and a specialized compounding business that provides customized formulations for unique patient needs. Harrow is committed to expanding access to innovative, affordable, and high-quality treatments to improve patient outcomes for a range of ocular conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all HARROW, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HARROW, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HARROW, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
